Anne Bodlenner

Dr. Anne Bodlenner

CNRS, Strasbourg, Grand Est, France
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
EHEduardo Howard
Eduardo Howard
ACAlexandra Cousido‐Siah
Alexandra Cousido‐Siah
MLMathieu L. Lepage
Mathieu L. Lepage
JSJérémy P. Schneider
Jérémy P. Schneider
ABAnne Bodlenner
Anne Bodlenner
Philippe CompainPhilippe Compain
Philippe Compain
Multivalent design of glycosidase inhibitors is a promising strategy for the treatment of diseases involving enzymatic hydrolysis of glycosidic bonds in carbohydrates. An essential prerequisite for successful applications is the atomic‐level understanding of how outstanding binding enhancement occurs with multivalent inhibitors. Herein we report the first high‐resolution crystal structures of the Jack bean α‐mannosidase (JBα‐man) in apo and inhibited states. The three‐dimensional structure of JBα‐man in complex with the multimeric cyclopeptoid‐based inhibitor displaying the largest binding enhancements reported so far provides decisive insight into the molecular mechanisms underlying multivalent effects in glycosidase inhibition.

25 January 2018 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
JNJean-François NIERENGARTEN
Jean-François NIERENGARTEN
JSJérémy P. Schneider
Jérémy P. Schneider
TTThi Minh Nguyet Trinh
Thi Minh Nguyet Trinh
AJAntoine Joosten
Antoine Joosten
MHMichel Holler
Michel Holler
Philippe CompainPhilippe Compain
Philippe Compain

3 April 2018 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
MPMaëva M. Pichon
Maëva M. Pichon
FSFabien Stauffert
Fabien Stauffert
LALuis G. Addante‐Moya
Luis G. Addante‐Moya
ABAnne Bodlenner
Anne Bodlenner
Philippe CompainPhilippe Compain
Philippe Compain

5 November 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JSJérémy P. Schneider
Jérémy P. Schneider
STStefano Tommasone
Stefano Tommasone
PSPaolo Della Sala
Paolo Della Sala
Carmine GaetaCarmine Gaeta
Carmine Gaeta
CTCarmen Talotta
Carmen Talotta
Philippe CompainPhilippe Compain
Philippe Compain
A set of 6- to 24-valent clusters was constructed with terminal deoxynojirimycin (DNJ) inhibitory heads through C6 or C9 linkers by way of Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reactions between mono- or trivalent azido-armed iminosugars and calix[8]arene scaffolds differing in their valency and their rigidity but not in their size. The power of multivalency to upgrade the inhibition potency of the weak DNJ inhibitor (monovalent DNJ Ki being at 322 and 188 µM for C6 or C9 linkers, respectively) was evaluated on the model glycosidase Jack Bean α-mannosidase (JBα-man). Although for the clusters with the shorter C6 linker the rigidity of the scaffold was essential, these parameters had no influence for clusters with C9 chains: all of them showed rather good relative affinity enhancements per inhibitory epitopes between 70 and 160 highlighting the sound combination of the calix[8]arene core and the long alkyl arms. Preliminary docking studies were performed to get insights into the preferred binding modes.

12 April 2017 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
FSFabien Stauffert
Fabien Stauffert
JSJenny Serra-Vinardell
Jenny Serra-Vinardell
MGMarta Gómez-Grau
Marta Gómez-Grau
HMHelen Michelakakis
Helen Michelakakis
IMIrene Mavridou
Irene Mavridou
Philippe CompainPhilippe Compain
Philippe Compain
A library of dimers and heterodimers of both enantiomers of 2-O-alkylated iminoxylitol derivatives has been synthesised and evaluated on β-glucocerebrosidase (GCase), the enzyme responsible for Gaucher disease (GD). Although the objective was to target simultaneously the active site and a secondary binding site of the glucosidase, the (−)-2-iminoxylitol moiety seemed detrimental for imiglucerase inhibition and no significant enhancement was obtained in G202R, N370S and L444P fibroblasts. However, all compounds having at least one (+)-2-O-alkyl iminoxylitol are GCase inhibitors in the nano molar range and are significant GCase activity enhancers in G202R fibroblats, as confirmed by a decrease of glucosylceramide levels and by co-localization studies.

21 May 2019 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MPMaëva M. Pichon
Maëva M. Pichon
FSFabien Stauffert
Fabien Stauffert
ABAnne Bodlenner
Anne Bodlenner
Philippe CompainPhilippe Compain
Philippe Compain
The best multivalent effects observed in glycosidase inhibition have been achieved so far with jack bean α-mannosidase (JBα-man) using iminosugar clusters based on weakly binding mismatching active-site-directed inhibiting epitopes (inhitopes) in the D-gluco series. Here, we synthesize and evaluate as JBα-man inhibitors a series of mono- to 14-valent glycoimidazoles with inhitopes displaying inhibition values up to the range of hundreds of nMs to study the impact of inhitope affinity on the multivalent effect. The most potent inhibitor of the series, a 14-valent mannoimidazole derivative, inhibits JBα-man with a nanomolar Ki value (2 ± 0.5 nM) and binding enhancements observed are, at best, relatively small (up to 25-fold on a valency-corrected basis). The results of this study support the fact that JBα-man-inhitope affinity and the strength of the inhibitory multivalent effect evolve in the opposite direction. The major impact of the glycoimidazole-based inhitope is found on the binding scenario; most of the synthesized mannoimidazole clusters as well as a 14-valent glucoimidazole derivative prove to be tight binding inhibitors of JBα-man.